{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:12:13Z","timestamp":1776525133572,"version":"3.51.2"},"reference-count":16,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,2,5]]},"DOI":"10.1248\/bpb.b24-00662","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T22:11:58Z","timestamp":1738707118000},"page":"108-114","source":"Crossref","is-referenced-by-count":2,"title":["Irinotecan-Induced Site-Specific Pigmentation in the Plantar Region of Mice"],"prefix":"10.1248","volume":"48","author":[{"given":"Masashi","family":"Imai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500\u20133 Minamitamagaki, Suzuka, Mie 513\u20138607, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500\u20133 Minamitamagaki, Suzuka, Mie 513\u20138607, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500\u20133 Minamitamagaki, Suzuka, Mie 513\u20138607, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500\u20133 Minamitamagaki, Suzuka, Mie 513\u20138607, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ooi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500\u20133 Minamitamagaki, Suzuka, Mie 513\u20138607, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Saadet ED, Tek I. Evaluation of chemotherapy-induced cutaneous side effects in cancer patients. <i>Int. J. Dermatol<\/i>., <b>61<\/b>, 1519\u20131526 (2022).","DOI":"10.1111\/ijd.16361"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ciaffaglione V, Modica MN, Pittal\u00e0 V, Romeo G, Salerno L, Intagliata S. Mutual prodrugs of 5-fluorouracil: from a classic chemotherapeutic agent to novel potential anticancer drugs. <i>ChemMedChem<\/i>, <b>16<\/b>, 3496\u20133512 (2021).","DOI":"10.1002\/cmdc.202100473"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Malet-Martino M, Martino R. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. <i>Oncologist<\/i>, <b>7<\/b>, 288\u2013323 (2002).","DOI":"10.1634\/theoncologist.7-4-288"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fujito A, Hiramoto K, Imai M, Tanaka S, Ooi K. ACTH\/cAMP-mediated skin pigmentation caused by 5-fluorouracil administration. <i>Biol. Pharm. Bull<\/i>., <b>46<\/b>, 955\u2013963 (2023).","DOI":"10.1248\/bpb.b23-00108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fujito A, Tanaka S, Hiramoto K, Ma N, Ooi K. The mechanism of 5-fluorouracil-induced hyperpigmentation in HRM-2 hairless mice: focus on the increase of blood vessels. <i>Biol. Pharm. Bull<\/i>., <b>47<\/b>, 311\u2013317 (2024).","DOI":"10.1248\/bpb.b23-00584"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bailly C. Irinotecan: 25 years of cancer treatment. <i>Pharmacol. Res<\/i>., <b>148<\/b>, 104398 (2019).","DOI":"10.1016\/j.phrs.2019.104398"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Gaurav V, Singal A. Irinotecan-induced serpentine supravenous hyper-pigmentation. <i>Indian J. Dermatol<\/i>., <b>67<\/b>, 779\u2013781 (2022).","DOI":"10.4103\/ijd.ijd_397_22"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nestor LA, Flint S, Galvin S. Unusual case of hyperpigmentation secondary to irinotecan. <i>BMJ Case Rep<\/i>., <b>2016<\/b>, bcr-2016-217545 (2016).","DOI":"10.1136\/bcr-2016-217545"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jimbow K, Uesugi T. New melanogenesis and photobiological processes in activation and proliferation of precursor melanocytes after UV-exposure: ultrastructural differentiation of precursor melanocytes from Langerhans cells. <i>J. Invest. Dermatol<\/i>., <b>78<\/b>, 108\u2013115 (1982).","DOI":"10.1111\/1523-1747.ep12505758"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) D\u2019Mello SAN, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. <i>Int. J. Mol. Sci<\/i>., <b>17<\/b>, 1144 (2016).","DOI":"10.3390\/ijms17071144"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lu Y, Tonissen KF, Di Trapani G. Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis. <i>Biosci. Rep<\/i>., <b>41<\/b>, BSR20210427 (2021).","DOI":"10.1042\/BSR20210427"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Boulton SJ, Birch-Machin MA. Impact of hyperpigmentation on superoxide flux and melanoma cell metabolism at mitochondrial complex II. <i>FASEB J<\/i>., <b>29<\/b>, 346\u2013353 (2015).","DOI":"10.1096\/fj.14-261982"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Chen P, Luo X, Nie P, Wu B, Xu W, Shi X, Chang H, Li B, Yu X, Zou Z. CQ synergistically sensitizes human colorectal cancer cells to SN-38\/CPT-11 through lysosomal and mitochondrial apoptotic pathway <i>via<\/i> p53-ROS cross-talk. <i>Free Radic. Biol. Med<\/i>., <b>104<\/b>, 280\u2013297 (2017).","DOI":"10.1016\/j.freeradbiomed.2017.01.033"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Singh R, Shankar BS, Sainis KB. TGF-\u03b21-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells. <i>Cell. Signal<\/i>., <b>26<\/b>, 1604\u20131615 (2014).","DOI":"10.1016\/j.cellsig.2014.03.028"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hua J, Chen H, Chen Y, Zheng G, Li F, Qu J, Ma X, Hou L. MITF acts as an anti-oxidant transcription factor to regulate mitochondrial biogenesis and redox signaling in retinal pigment epithelial cells. <i>Exp. Eye Res<\/i>., <b>170<\/b>, 138\u2013147 (2018).","DOI":"10.1016\/j.exer.2018.02.023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yang B, Xie X, Lv D, Hu J, Chen Y, Wu Z, Luo S, Zhang S. Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil. <i>Br. J. Cancer<\/i>, <b>128<\/b>, 219\u2013231 (2023).","DOI":"10.1038\/s41416-022-02039-3"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/2\/48_b24-00662\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:26:44Z","timestamp":1738985204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/2\/48_b24-00662\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00662","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"b24-00662"}}